Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Second-line Chemotherapy in Castration Resistant Prostate Cancer (ProstyII)

This study has been completed.
Sponsor:
Collaborators:
Helsinki University Central Hospital
Turku University Hospital
Kuopio University Hospital
Seinajoki Central Hospital
Information provided by (Responsible Party):
Tampere University Hospital
ClinicalTrials.gov Identifier:
NCT01558219
First received: November 25, 2011
Last updated: October 20, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2014
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)